- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | RANGE IMPACT, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.05. | Range Impact GAAP EPS of $0.05, revenue of $0.7M | 3 | Seeking Alpha | ||
| RANGE IMPACT Aktie jetzt für 0€ handeln | |||||
| 15.05. | Range Impact, Inc.: Range Impact Reports 1Q 2025 Financial Results | 65 | GlobeNewswire (Europe) | Cleveland, Ohio, May 15, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public impact investing company dedicated to acquiring, reclaiming and repurposing... ► Artikel lesen | |
| 02.04. | Range Impact, Inc.: Range Impact Announces Major Land Acquisition in West Virginia | 81 | GlobeNewswire (Europe) | CLEVELAND, OHIO, April 02, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public company dedicated to acquiring, reclaiming and repurposing distressed... ► Artikel lesen | |
| 02.04. | RANGE IMPACT, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.01. | RANGE IMPACT, INC. - 8-K, Current Report | - | SEC Filings | ||
| 19.12.24 | RANGE IMPACT, INC. - S-1/A, General form for registration of securities | - | SEC Filings | ||
| 07.10.24 | Range Impact, Inc.: Range Impact Announces Uplisting to the OTCQB Venture Market | 183 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public company dedicated to improving the health and wellness of people and... ► Artikel lesen | |
| 02.10.24 | Range Impact, Inc.: Range Impact Announces Sale of Cannabinoid Drug Development Business | 159 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact" or the "Company"), a public company dedicated to improving the health and wellness of people and the... ► Artikel lesen | |
| 29.08.24 | Range Impact, Inc.: Range Impact Announces Sale of Non-Core Assets as Part of Strategic Plan | 274 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact" or the "Company"), a public company dedicated to improving the health and wellness of people and the... ► Artikel lesen | |
| 14.08.24 | Range Impact, Inc.: Range Impact Reports 2Q 2024 Financial Results | 385 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact"), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites... ► Artikel lesen |
11 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 65,55 | +2,49 % | SCHOCK bei Renk, Novo Nordisk Aktie "KAUFEN", PanGenomic Health auf den Spuren von Hims & Hers | Schock bei Renk & Co.! Gestern Nachmittag machte die Nachricht die Runde, dass die EU den Rüstungskonzernen an die Milliardengewinne gehen will. Schließlich stehen die Unternehmen vor goldenen Zeiten.... ► Artikel lesen | |
| AURORA CANNABIS | 5,030 | +0,20 % | Aurora Cannabis Inc (3): Aurora Cannabis launches IndiMed Tempo 22 | ||
| CANOPY GROWTH | 1,498 | +0,67 % | Canopy Growth has price target chopped at Roth | ||
| TILRAY BRANDS | 0,357 | +0,11 % | Tilray Brands Inc: Tilray Brands to be deleted from S&P/TSX Composite | ||
| VERTEX PHARMACEUTICALS | 395,50 | +0,08 % | Vertex Pharmaceuticals Incorporated: Vertex Presents New Data on Benefits of ALYFTREK and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference | - Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with... ► Artikel lesen | |
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT clarifies disclosure about Premium Products buy | ||
| CRONOS GROUP | 1,728 | -0,80 % | Cronos Group Inc.: Cronos Group Reports 2025 First Quarter Results | Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis PEACE NATURALS® retained its position as the number one cannabis brand in... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Provides Update Regarding Proposed RTO Transaction | / Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or... ► Artikel lesen | |
| EYEPOINT PHARMACEUTICALS | 7,718 | -1,56 % | EyePoint Pharmaceuticals, Inc.: EyePoint Completes Enrollment in Pivotal Phase 3 LUGANO Trial of DURAVYU for Treatment of Wet Age-Related Macular Degeneration | - Over 400 patients enrolled and randomized over a seven-month period, driven by strong physician and patient interest - - LUCIA pivotal Phase 3 trial continues rapid enrollment pace with 60% of... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,170 | -1,68 % | Organigram Global Inc. reicht 6-K Bericht bei der SEC ein | ||
| GREEN THUMB INDUSTRIES | 4,600 | +0,97 % | Green Thumb Industries Inc: Green Thumb to hold cannabis, music festival | ||
| MYDECINE INNOVATIONS GROUP | 0,002 | -80,00 % | Aquis Stock Exchange: Withdrawal from Trading - Mydecine Innovations Group Inc. | Aquis Stock Exchange
Aquis Stock Exchange: Withdrawal from Trading 02-Apr-2025 / 07:00 GMT/BST
The issuer is solely responsible for the content of this... ► Artikel lesen | |
| ASTRIA THERAPEUTICS | 5,250 | -0,94 % | Astria Therapeutics, Inc.: Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Annual Congress | Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present four... ► Artikel lesen | |
| SANTHERA PHARMACEUTICALS | 13,980 | -5,41 % | Santhera Pharmaceuticals Holding AG: Santheras Aktionäre stimmen an der heutigen Generalversammlung allen Anträgen des Verwaltungsrats zu | Pratteln, Schweiz, 20. Mai 2025 - Santhera Pharmaceuticals (SIX: SANN) gibt heute bekannt, dass die Aktionäre an der heutigen Generalversammlung (GV) in Pratteln, Schweiz, allen Anträgen des Verwaltungsrates... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 36,000 | +1,12 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction | Investigator-initiated Phase 2 trial to evaluate TNX-102 SL's potential to reduce severity of acute stress reaction (ASR) and frequency of acute stress disorder (ASD) Trial is sponsored by the University... ► Artikel lesen |
RANGE IMPACT INC gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RANGE IMPACT INC finden Sie auf Wallstreet Online.